Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $16.18 in the prior trading day, Mineralys Therapeutics Inc (NASDAQ: MLYS) closed at $15.52, down -4.08%. In other words, the price has decreased by -$4.08 from its previous closing price. On the day, 0.57 million shares were traded.
Ratios:
Our goal is to gain a better understanding of MLYS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.48 and its Current Ratio is at 26.48. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 10, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On April 02, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $30.
On March 07, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $27.Wells Fargo initiated its Overweight rating on March 07, 2023, with a $27 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Rodman David Malcom sold 11,366 shares for $15.29 per share. The transaction valued at 173,774 led to the insider holds 106,669 shares of the business.
Rodman David Malcom bought 11,366 shares of MLYS for $173,774 on May 14 ’25. On Mar 13 ’25, another insider, Slingsby Brian Taylor, who serves as the Director of the company, bought 259,259 shares for $13.50 each. As a result, the insider paid 3,499,996 and bolstered with 8,903,838 shares of the company.
Stock Price History:
Over the past 52 weeks, MLYS has reached a high of $18.38, while it has fallen to a 52-week low of $8.24. The 50-Day Moving Average of the stock is 6.25%, while the 200-Day Moving Average is calculated to be 22.15%.
Shares Statistics:
A total of 64.88M shares are outstanding, with a floating share count of 40.49M. Insiders hold about 37.88% of the company’s shares, while institutions hold 65.21% stake in the company.
